Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 23, 2005

View Archived Issues

Stat3 identified as a novel target for contraception

(R)-Etodolac is cytotoxic to multiple myeloma cells in vitro and ex vivo

Mycophenolate mofetil reduces activity of refractory systemic lupus erythematosus

MT-103 deemed safe and effective in studies with chimpanzees

NN-1731 offers a better hemostatic potential than recombinant FVIIa

Novel agents for treating eating disorders claimed by sanofi-aventis

Novel therapeutics for cardiovascular diseases reported

Companies disclose new treatments for diabetes

Antiretroviral efficacy of stampidine is evident in FIV-infected cats

Defibrotide and oligotide prevent chemotherapy-induced damage of endothelial cells

Bezafibrate and medroxyprogesterone enter phase II studies for AML treatment

Biovitrum and Santhera sign license agreement for DPP-IV program

Phase II study of oxypurinol fails to meet endpoints

Dosing completed in first part of phase I study of ACV-1

Epimmune and IDM join to become IDM Pharma

AMDL's DR-70 test shows utility in detecting ovarian cancer

Target selected in Celera Genomics and Seattle Genetics' collaboration

Targeting microglia relieves spinal cord injury pain

In vivo effects of TRPV1 antagonism for pain associated with gastroesophageal reflux

Antiinflammatory effects of a novel EP4 agonist

X-Cell Medical begins study of estradiol-eluting stent

Crucell and U.S. Navy sign CRADA for AdVac vaccines for anthrax and plague

Large Scale Biology and BioCatalytics enter collaboration agreement

Odyssey Thera and NIH to advance Molecular Libraries Roadmap Initiative

Chiron obtains PER.C6 research license

Safety, tolerability and antiviral efficacy of GW-695634 in NNRTI-resistant HIV-1-infected patients

Singulair approved for symptoms of perennial allergic rhinitis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...